Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol for general anesthesia in renal transplantation
ChiCTR2200058826Phase 4Recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Jun 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in end-stage kidney disease (ESKD) (2 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoint: Successful sedation. Started Jun 2021; status: recruiting.
02
Drugs
ciprofol
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2200058826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058826.